Dual antiplatelet therapy with aspirin and clopidogrel, a P2Y12 antagonist, is a cornerstone for treatment of patients with stroke, peripheral arterial disease, and acute coronary artery disease followed with or without percutaneous coronary intervention. Giachini and colleagues found that clopidogrel could normalize the increased phenylephrine-induced vascular contraction and impaired acetylcholine-induced vasodilatation in mesenteric arteries from angiotensin II-infused Sprague-Dawley rats. This might develop a new area for clopidogrel application. However, whether clopidogrel can improve the arterial function in patients with hypertension or diabetes, or whether clopidogrel outweighs the beneficial effect aspirin in those patients, remains an open field for future inquiry.
See the original post:
Clopidogrel application: beyond coronary artery disease
Tags: a-new-area, beneficial, could-normalize, for-clopidogrel, increased
Related posts:
- Clopidogrel, independent of vascular P2Y12 receptor, improves the arterial function in small mesenteric arteries from Ang II-hypertensive rats
- Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated type 2 diabetic patients
- Central and cerebrovascular effects of leg crossing in humans with sympathetic failure
- Hypoxia and non alcoholic fatty liver disease
- A translational study of circulating cell-free microRNA-1 in acute myocardial infarction
Related posts brought to you by Yet Another Related Posts Plugin.
